NVCT
Price
$6.91
Change
+$0.21 (+3.13%)
Updated
Sep 19, 10:37 AM (EDT)
48 days until earnings call
SNDX
Price
$18.52
Change
+$0.51 (+2.83%)
Updated
Sep 19, 10:53 AM (EDT)
48 days until earnings call
Ad is loading...

NVCT vs SNDX

Header iconNVCT vs SNDX Comparison
Open Charts NVCT vs SNDXBanner chart's image
Nuvectis Pharma
Price$6.91
Change+$0.21 (+3.13%)
Volume$200
CapitalizationN/A
Syndax Pharmaceuticals
Price$18.52
Change+$0.51 (+2.83%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
NVCT vs SNDX Comparison Chart
Loading...
NVCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
NVCT vs. SNDX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVCT is a Hold and SNDX is a Hold.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (NVCT: $6.70 vs. SNDX: $18.00)
Brand notoriety: NVCT and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVCT: 99% vs. SNDX: 198%
Market capitalization -- NVCT: $124.04M vs. SNDX: $1.53B
NVCT [@Biotechnology] is valued at $124.04M. SNDX’s [@Biotechnology] market capitalization is $1.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $599.73B to $0. The average market capitalization across the [@Biotechnology] industry is $3.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVCT’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • NVCT’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, SNDX is a better buy in the long-term than NVCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVCT’s TA Score shows that 5 TA indicator(s) are bullish while SNDX’s TA Score has 4 bullish TA indicator(s).

  • NVCT’s TA Score: 5 bullish, 4 bearish.
  • SNDX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NVCT is a better buy in the short-term than SNDX.

Price Growth

NVCT (@Biotechnology) experienced а +4.04% price change this week, while SNDX (@Biotechnology) price change was -1.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +7.58%, and the average quarterly price growth was +1.88%.

Reported Earning Dates

NVCT is expected to report earnings on Nov 06, 2024.

SNDX is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($1.53B) has a higher market cap than NVCT($124M). SNDX YTD gains are higher at: -16.705 vs. NVCT (-19.664). NVCT has higher annual earnings (EBITDA): -22.06M vs. SNDX (-263.84M). SNDX has more cash in the bank: 432M vs. NVCT (18.1M). SNDX has higher revenues than NVCT: SNDX (3.5M) vs NVCT (0).
NVCTSNDXNVCT / SNDX
Capitalization124M1.53B8%
EBITDA-22.06M-263.84M8%
Gain YTD-19.664-16.705118%
P/E RatioN/AN/A-
Revenue03.5M-
Total Cash18.1M432M4%
Total DebtN/A1.13M-
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
55
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVCTSNDX
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 25 days ago
83%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
67%
View a ticker or compare two or three
Ad is loading...
NVCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CPXRX15.890.01
+0.06%
Columbia Mid Cap Index Inst2
JDCAX56.11N/A
N/A
Janus Henderson Forty A
HEIFX15.45-0.01
-0.06%
Hennessy Equity and Income Investor
JASOX25.90-0.02
-0.08%
JHancock New Opportunities A
BIRCX20.97-0.05
-0.24%
BlackRock Sustainable Adg Lg Cp Cr C

NVCT and

Correlation & Price change

A.I.dvisor tells us that NVCT and KRYS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and KRYS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
+0.75%
KRYS - NVCT
33%
Poorly correlated
-3.44%
GERN - NVCT
31%
Poorly correlated
-0.66%
DARE - NVCT
30%
Poorly correlated
+2.47%
FUSN - NVCT
30%
Poorly correlated
N/A
SNDX - NVCT
26%
Poorly correlated
-0.33%
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with RCUS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then RCUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
-0.33%
RCUS - SNDX
50%
Loosely correlated
-1.43%
BPMC - SNDX
48%
Loosely correlated
+3.26%
NTLA - SNDX
46%
Loosely correlated
-0.13%
FOLD - SNDX
46%
Loosely correlated
-2.59%
RAPT - SNDX
45%
Loosely correlated
-4.21%
More